Table 3.
The effects of the selected herbal substances on pharmacokinetics and pharmacodynamics [28,33,34,50,51,52,61,67,68,69,70].
| Herb | Active Component | Relevant Metabolizing Enzymes/Transporters/Mechanism of Actions | Pharmacokinetics of Tacrolimus |
Impact on Organism |
|---|---|---|---|---|
| Panax ginseng | Ginsenosides Glycosylated intestinal metabolites |
Poor inhibition of CYP2D6; Poor inhibition of P-gp; Poor induction of CYP3A; Promotion of Klotho signalling pathway | Poor increase or lack of impact on TAC serum level | Poor or no aggravation of TAC toxicity, a decrease in oxidative stress with a reduction in TAC-induced nephrotoxicity |
| Green tea | Catechins Theaflavins |
Inhibition of CYPs; Inhibition of P-gp; Promotion of Klotho signalling pathway |
Inconclusive data | A decrease in oxidative stress with a reduction in TAC-induced nephrotoxicity |
| Echinacea purpurea | - | Inconclusive data | Inconclusive data | Inconclusive data |
| Hypericum perforatum | Hyperforin Hypericin |
Induction of CYP3A4; Induction of P-gp |
A decrease in TAC serum level | Increased risk of transplant rejection |
TAC—tacrolimus; P-gp—P-glycoprotein.